JFitzgibbon
TL2 Member · Valladolid, ES
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 21 September 2025 · last posted 5d
86Posts here
1Topics
1Solutions
591Likes received
447Likes given
18Badges
159Days visited
2.3kPosts read
Recent activity
Full stream-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #129 · Evidence › Journal club · 23 Jul 2026 · 28 likes Counterpoint on orforglipron phase 2, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
-
Documenting a supplier's response to a discrepancy Replied, post #43 · Sourcing › Vendor reports · 20 Jul 2026 · 23 likes Picking up post #42: that is the part I would want checked first. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #119 · Evidence › Journal club · 19 Jul 2026 · 12 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. The…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #27 · Evidence › Preprints · 17 Jul 2026 · 29 likes I had written a reply contradicting post #26 and deleted it. Here is what survived. Two sentences on community labels and then I will stop, because the rest is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #64 · Practice › Dosing & titration · 14 Jul 2026 · 0 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #36 · Start Here › Welcome · 12 Jul 2026 · 32 likes Marking my uncertainty on Reading order explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #83 · Practice › Interactions · 11 Jul 2026 · 11 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #15 · Clinical › Comorbidities · 10 Jul 2026 · 0 likes Osteoarthritis and mechanical versus metabolic is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #7 · Access › Insurance & coverage · 7 Jul 2026 · 4 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Date every account in this subcategory. Payer criteria change frequently and the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #41 · Start Here › Welcome · 25 Jun 2026 · 0 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
-
Preservatives: function, testing, and limits — one year on Replied, post #26 · Pharmacology › Formulation chemistry · 23 Jun 2026 · 0 likes The reason Preservatives keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #99 · Evidence › Journal club · 22 Jun 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. I would not…